ArticleCancer gene therapy2004
Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
John Irving et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it